Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C
- 1 May 2000
- journal article
- research article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 7 (3) , 211-217
- https://doi.org/10.1046/j.1365-2893.2000.00215.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Reduction of Health–Related Quality of Life in Chronic Hepatitis C and Improvement With Interferon TherapyHepatology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998
- Hepatitis C virus and depression in drug usersAmerican Journal of Gastroenterology, 1998
- Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisHepatology, 1998
- Dose-finding study of interferon alfa-n3 in hepatitisHepatology, 1997
- A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis CQuality of Life Research, 1997
- Health assessment for chronic HCV infectionDigestive Diseases and Sciences, 1996
- Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter triaHepatology, 1996
- High-dose interferon-α2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis CDigestive Diseases and Sciences, 1996